Search results
Results from the WOW.Com Content Network
On rare occasion, infarcts in the hippocampus or thalamus are the cause of dementia. [12] A history of stroke increases the risk of developing dementia by around 70%, and recent stroke increases the risk by around 120%. [13] Brain vascular lesions can also be the result of diffuse cerebrovascular disease, such as small vessel disease. [5]
Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. [14] It is indicated in the treatment of schizophrenia and schizoaffective disorder . [ 14 ] It is marketed by Janssen Pharmaceuticals .
Researchers found that every change in these indicators was linked to an increased stroke risk of 10-19%. ... “Stroke remains a leading cause of disability and death globally, with many cases ...
Here’s what you need to know about how memory loss can be a sign of more serious cognitive impairment. ... Certain prescription and over-the-counter drugs can cause sleepiness or confusion ...
Brain ischemia has been linked to a variety of diseases or abnormalities. Individuals with sickle cell anemia, compressed blood vessels, ventricular tachycardia, plaque buildup in the arteries, blood clots, extremely low blood pressure as a result of heart attack, and congenital heart defects have a higher predisposition to brain ischemia in comparison to the average population.
Mild cognitive impairment (MCI) may be caused due to alteration in the brain triggered during early stages of Alzheimer's disease, to other causes, or to a combination of causes. [14] [15] Brain damage, brain injury, delirium and prolonged substance abuse can cause MCI. HIV-associated neurocognitive disorder can cause MCI. Risk factors of both ...
Damage to the limbic system involves loss or damage to memory, and may include: [citation needed] loss or confusion of long-term memory prior to focal neuropathy (retrograde amnesia) inability to form new memories (anterograde amnesia) loss of, or reduced emotions ; loss of olfactory functions; loss of decision-making ability
J&J sold more than $4.1 billion worth of Invega Sustenna and related drugs worldwide last year, with nearly $2.9 billion in U.S. sales, according to a company report. It sued Teva and Mylan, which ...